Cerberus sells remaining stake in pharma company Talecris | AltAssets Private Equity News

Subscribe today

Advanced
Search

Cerberus sells remaining stake in pharma company Talecris

7 Jun 2010

Private equity house Cerberus Capital Management has sold its stake in Talecris Biotherapeutics to Spanish pharmaceuticals company Grifols in a deal that puts a $3.4bn price tag on the business.

Sorry, to read the full story you must be a Premium Subscriber

Are you a subscriber?

In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.

Become a Premium Subscriber
for only £150 / €180 / $225 p.a.

Login area

If you are already a AltAssets subscriber please log in below.